SE414030B - Analogiforfarande for framstellning av kondenserade pyridinforeningar - Google Patents

Analogiforfarande for framstellning av kondenserade pyridinforeningar

Info

Publication number
SE414030B
SE414030B SE7303019A SE7303019A SE414030B SE 414030 B SE414030 B SE 414030B SE 7303019 A SE7303019 A SE 7303019A SE 7303019 A SE7303019 A SE 7303019A SE 414030 B SE414030 B SE 414030B
Authority
SE
Sweden
Prior art keywords
pyrides
compounds
analogy procedure
preparing condensed
condensed
Prior art date
Application number
SE7303019A
Other languages
English (en)
Inventor
H Meyer
F Bossert
W Vater
K Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE414030B publication Critical patent/SE414030B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7303019A 1972-03-06 1973-03-05 Analogiforfarande for framstellning av kondenserade pyridinforeningar SE414030B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210633A DE2210633C2 (de) 1972-03-06 1972-03-06 Kondensierte Pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
SE414030B true SE414030B (sv) 1980-07-07

Family

ID=5838002

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7303019A SE414030B (sv) 1972-03-06 1973-03-05 Analogiforfarande for framstellning av kondenserade pyridinforeningar

Country Status (18)

Country Link
US (1) US3856798A (sv)
JP (1) JPS5623993B2 (sv)
AT (1) AT324336B (sv)
BE (1) BE796276A (sv)
CA (1) CA1016544A (sv)
CH (1) CH593278A5 (sv)
DD (1) DD106386A5 (sv)
DE (1) DE2210633C2 (sv)
ES (1) ES412321A1 (sv)
FR (1) FR2181794B1 (sv)
GB (1) GB1384504A (sv)
HU (1) HU164568B (sv)
IE (1) IE37368B1 (sv)
IL (1) IL41669A (sv)
NL (1) NL7303133A (sv)
SE (1) SE414030B (sv)
SU (1) SU525424A3 (sv)
ZA (1) ZA731504B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971791A (en) * 1972-03-06 1976-07-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3971790A (en) * 1972-03-06 1976-07-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US4097598A (en) * 1976-08-06 1978-06-27 Pfizer Inc. Quaternary salts as hypoglycemic agents
CH638215A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-derivate.
CH638216A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-deriate.
US5237089A (en) * 1986-02-07 1993-08-17 Basf Aktiengesellschaft Nitro or amino substituted phenylalkyl or phenylalkenyl carboxylic acid derivatives
DE3606168A1 (de) * 1986-02-26 1987-08-27 Basf Ag Zimtsaeurepropargylester, verfahren zu ihrer herstellung und ihre verwendung zur schaedlingsbekaempfung
IL91382A (en) * 1988-09-01 1995-06-29 Orion Yhtymae Oy Dicitons are converted into alkanyl or ethylmethylene, through their preparation and pharmaceutical preparations containing them
US5185370A (en) * 1988-09-01 1993-02-09 Orion-Yhtyma Oy Substituted β-diketones and their use
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
IT1249210B (it) * 1990-06-08 1995-02-20 Boehringer Mannheim Italia ¬3h,7h| tiazolo-¬3,4-a| piridine ad attivita' antiasmatica e antiinfiammatoria delle vie aeree
IT1252627B (it) * 1991-12-06 1995-06-19 Boehringer Mannehim Italia S P ¬3h,7h| tiazolo ¬3,4-a| piridine ad attivita' antiasmatica e antiinfiammatoria delle vie aeree
IT1252626B (it) * 1991-12-06 1995-06-19 Boehringer Mannheim Italia ¬3h, 7h| tiazolo ¬3,4a| piridine ad attivita' antiasmatica ed antiinfiammatoria delle vie aeree
US5508272A (en) * 1993-06-15 1996-04-16 Bristol-Myers Squibb Company Compounds containing a fused bicycle ring and processes therefor
US5616775A (en) * 1994-05-05 1997-04-01 Bristol-Myers Squibb Co. Process for preparing homocystein analogs useful as intermediates for compounds containing a fused bicyclic ring
DE4444860A1 (de) * 1994-12-16 1996-06-20 Bayer Ag Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als Arzneimittel
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784600A (en) * 1971-10-22 1974-01-08 Warner Lambert Co 4-substituted coumarins

Also Published As

Publication number Publication date
IE37368L (en) 1973-09-06
AT324336B (de) 1975-08-25
NL7303133A (sv) 1973-09-10
FR2181794A1 (sv) 1973-12-07
JPS5623993B2 (sv) 1981-06-03
DE2210633C2 (de) 1983-09-22
IE37368B1 (en) 1977-07-06
SU525424A3 (ru) 1976-08-15
DD106386A5 (sv) 1974-06-12
FR2181794B1 (sv) 1976-10-22
IL41669A0 (en) 1973-08-29
BE796276A (fr) 1973-09-05
CA1016544A (en) 1977-08-30
DE2210633A1 (de) 1973-09-20
JPS4899193A (sv) 1973-12-15
HU164568B (sv) 1974-03-28
CH593278A5 (sv) 1977-11-30
ES412321A1 (es) 1976-01-01
US3856798A (en) 1974-12-24
GB1384504A (en) 1975-02-19
ZA731504B (en) 1973-11-28
IL41669A (en) 1976-10-31

Similar Documents

Publication Publication Date Title
SE395366B (sv) Forfarande for framstellning av porosa tabletter
NO149176C (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
SE414030B (sv) Analogiforfarande for framstellning av kondenserade pyridinforeningar
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE7308234L (sv) Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
NO140828C (no) Fremgangsmaate for fremstilling av pullulan
NO139124C (no) Fremgangsmaate for fremstilling av estere
DK151628C (da) Analogifremgangsmaade til fremstilling af benzimidazolderivater
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
FI55626C (fi) Anordning foer framstaellning av en behaollare
NO137279C (no) Fremgangsm}te for oppberedning av findelte polyolefiner
SE428692B (sv) Forfarande for framstellning av 7beta-amino-3-cefem-4-karboxylsyraforeningar
NO139130C (no) Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner
SE417198B (sv) Analogiforfarande for framstellning av alkanolaminderivat
SE415146B (sv) Forfarande for framstellning av forbettrad epoxideringskatalysator
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
DK140668B (da) Analogifremgangsmåde til fremstilling af kondenserede pyriminderivater.
SE416953B (sv) Analogiforfarande for framstellning av substituerade fenylamidinokarbamidforeningar
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen